<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01763567</url>
  </required_header>
  <id_info>
    <org_study_id>CEP244</org_study_id>
    <nct_id>NCT01763567</nct_id>
  </id_info>
  <brief_title>Feasibility Study to Evaluate Safety and Device Performance of the Hospital Glucose Management System (HGMS)</brief_title>
  <acronym>MAHI</acronym>
  <official_title>A Multi-Phased, Multi-Center Study to Evaluate Safety and Device Performance of the Medtronic Hospital Glucose Management System (HGMS) in Critically Ill Adult Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Diabetes</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Diabetes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess safety and device performance of the Medtronic
      Hospital Glucose Management System (HGMS) for up to 72-hours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Assess safety and device performance of the Medtronic HGMS in the critically-ill setting and
      analyze the following:

        1. Device Performance:

             -  Functionality of HGMS

             -  Alerts/Alarms Specificity and Sensitivity

             -  System Workflow

        2. Safety:

             -  Descriptive statistics will be used to characterize safety events

             -  Moderate and severe anticipated device and procedure related adverse events

             -  All serious adverse events and unanticipated adverse device effects related events
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Device Performance: Accuracy of HGMS</measure>
    <time_frame>up to 72 hours</time_frame>
    <description>Mean Absolute Relative Difference (MARD), calculated as the absolute difference of [(sensor glucose values - iSTAT glucose values) / iSTAT glucose values].
The portable i-STAT handheld makes patient-side testing easy:
Requires no special sample preparation or user calibration; maintenance is minimal
Weighs 18 ounces, making it portable
Patient-side testing is as easy as entering the operator and patient information into the handheld, inserting one of the several filled test cartridges, and then viewing test results:
The system prompts users step by step through the testing process
Operator and patient information can be entered via barcode scanner
Operator lockout prevents unauthorized users from performing or viewing test results
Test results are uploaded automatically when the i-STAT handheld is placed in a downloader</description>
  </primary_outcome>
  <other_outcome>
    <measure>Functionality of HGMS: Alerts and Alarms - % of Hypo Events Correctly Detected</measure>
    <time_frame>up to 72 hours</time_frame>
    <description>The device alarmed within 30 minutes before or after the reference blood glucose value (i-STAT) goes below 70 mg/dL setting levels. The % of hypo events correctly detected was calculated as: total number of correct events divided by total number of events from all 19 participants.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functionality of HGMS: Alerts and Alarms - % of Hyper Events Correctly Detected</measure>
    <time_frame>72 hours</time_frame>
    <description>The device alarmed within 30 minutes before or after the reference blood glucose value (i-STAT) goes above 250 mg/dL setting levels. The % of hyper events correctly detected was calculated as: total number of correct events divided by total number of events from all 19 participants.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functionality of HGMS: Alerts and Alarms - % of Hypo False Alert</measure>
    <time_frame>Up to 72 hours</time_frame>
    <description>Definition of % of hypo false alert: within 30 minutes before or after the sensor alarmed at 70 mg/dL, there is no reference blood glucose value (i-STAT) that goes below 70 mg/dL. The % of hypo false alert was calculated as: total number of false events divided by total number of events from all 19 participants. NOTE: % of Hypo False Alert and % Hypo Event Correctly Detected do not necessarily add up to 100% because the denomintors are not the same.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functionality of HGMS: Alerts and Alarms - % of Hyper False Alert</measure>
    <time_frame>Up to 72 hours</time_frame>
    <description>Definition of % of Hyper False Alert: within 30 minutes before or after the sensor alarmed at 250 mg/dL, there is no reference blood glucose value (i-STAT) that goes above 250mg/dL . The % of hyper false alert was calculated as: total number of false events divided by total number of events from all 19 participants. NOTE: % of Hyper False Alert and % Hyper Event Correctly Detected do not necessarily add up to 100% because the denomintors are not the same.</description>
  </other_outcome>
  <enrollment type="Actual">19</enrollment>
  <condition>Hyperglycemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients admitted to the Intensive Care Unit (ICU) and on intravenous (IV) insulin
        therapy for the treatment of transient or diabetes-related hyperglycemia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is at least 18 years old

          2. Subject is admitted to the ICU

          3. Subject has a treatment regimen that includes a glucose target range of â‰¥140 mg/dl

          4. Subject has a treatment regimen that includes an intended continuous intravenous
             insulin for at least 24 hours

             a. Including patients with no previous diagnosis of Diabetes Mellitus

          5. Subject has anticipated life expectancy greater than 96 hours

          6. Subject has recent platelet count greater than 30,000 per micro-liter

        Exclusion Criteria:

          1. Subject currently has a suspected or diagnosed medical condition that, in the opinion
             of the Investigator, warrants exclusion from the study or prevents the subject from
             completing the study

          2. Subject is currently participating in another investigational drug or device study

          3. Subject is pregnant, as determined by hospital admission

          4. Subject is receiving treatment that includes Hydroxyurea.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mikhail Kosiborod, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Luke's Hospital - Mid America Heart Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Luke's Hospital Mid America Heart Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2012</study_first_submitted>
  <study_first_submitted_qc>January 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2013</study_first_posted>
  <results_first_submitted>October 14, 2014</results_first_submitted>
  <results_first_submitted_qc>May 5, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 7, 2015</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Medtronic</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Hospital</keyword>
  <keyword>Continuous Glucose Monitor</keyword>
  <keyword>Intensive Care Unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Oberservation Arm</title>
          <description>To assess safety and device performance for the Hospital Glucose Managment system</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Oberservation Arm</title>
          <description>To assess safety and device performance for the Hospital Glucose Managment system</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.2" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Device Performance: Accuracy of HGMS</title>
        <description>Mean Absolute Relative Difference (MARD), calculated as the absolute difference of [(sensor glucose values - iSTAT glucose values) / iSTAT glucose values].
The portable i-STAT handheld makes patient-side testing easy:
Requires no special sample preparation or user calibration; maintenance is minimal
Weighs 18 ounces, making it portable
Patient-side testing is as easy as entering the operator and patient information into the handheld, inserting one of the several filled test cartridges, and then viewing test results:
The system prompts users step by step through the testing process
Operator and patient information can be entered via barcode scanner
Operator lockout prevents unauthorized users from performing or viewing test results
Test results are uploaded automatically when the i-STAT handheld is placed in a downloader</description>
        <time_frame>up to 72 hours</time_frame>
        <population>To assess safety and device performance for the Hospital Glucose Managment system</population>
        <group_list>
          <group group_id="O1">
            <title>Oberservation Arm</title>
            <description>To assess safety and device performance for the Hospital Glucose Managment system</description>
          </group>
        </group_list>
        <measure>
          <title>Device Performance: Accuracy of HGMS</title>
          <description>Mean Absolute Relative Difference (MARD), calculated as the absolute difference of [(sensor glucose values - iSTAT glucose values) / iSTAT glucose values].
The portable i-STAT handheld makes patient-side testing easy:
Requires no special sample preparation or user calibration; maintenance is minimal
Weighs 18 ounces, making it portable
Patient-side testing is as easy as entering the operator and patient information into the handheld, inserting one of the several filled test cartridges, and then viewing test results:
The system prompts users step by step through the testing process
Operator and patient information can be entered via barcode scanner
Operator lockout prevents unauthorized users from performing or viewing test results
Test results are uploaded automatically when the i-STAT handheld is placed in a downloader</description>
          <population>To assess safety and device performance for the Hospital Glucose Managment system</population>
          <units>percent difference</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>12.8</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>9.5</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Functionality of HGMS: Alerts and Alarms - % of Hypo Events Correctly Detected</title>
        <description>The device alarmed within 30 minutes before or after the reference blood glucose value (i-STAT) goes below 70 mg/dL setting levels. The % of hypo events correctly detected was calculated as: total number of correct events divided by total number of events from all 19 participants.</description>
        <time_frame>up to 72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oberservation Arm</title>
            <description>To assess safety and device performance for the Hospital Glucose Managment system</description>
          </group>
        </group_list>
        <measure>
          <title>Functionality of HGMS: Alerts and Alarms - % of Hypo Events Correctly Detected</title>
          <description>The device alarmed within 30 minutes before or after the reference blood glucose value (i-STAT) goes below 70 mg/dL setting levels. The % of hypo events correctly detected was calculated as: total number of correct events divided by total number of events from all 19 participants.</description>
          <units>percentage of total events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percent of events correctly detected</param_type>
            <param_value>16.7</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Functionality of HGMS: Alerts and Alarms - % of Hyper Events Correctly Detected</title>
        <description>The device alarmed within 30 minutes before or after the reference blood glucose value (i-STAT) goes above 250 mg/dL setting levels. The % of hyper events correctly detected was calculated as: total number of correct events divided by total number of events from all 19 participants.</description>
        <time_frame>72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oberservation Arm</title>
            <description>To assess safety and device performance for the Hospital Glucose Managment system</description>
          </group>
        </group_list>
        <measure>
          <title>Functionality of HGMS: Alerts and Alarms - % of Hyper Events Correctly Detected</title>
          <description>The device alarmed within 30 minutes before or after the reference blood glucose value (i-STAT) goes above 250 mg/dL setting levels. The % of hyper events correctly detected was calculated as: total number of correct events divided by total number of events from all 19 participants.</description>
          <units>percentage of total events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percent of events correctly detected</param_type>
            <param_value>88.9</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Functionality of HGMS: Alerts and Alarms - % of Hypo False Alert</title>
        <description>Definition of % of hypo false alert: within 30 minutes before or after the sensor alarmed at 70 mg/dL, there is no reference blood glucose value (i-STAT) that goes below 70 mg/dL. The % of hypo false alert was calculated as: total number of false events divided by total number of events from all 19 participants. NOTE: % of Hypo False Alert and % Hypo Event Correctly Detected do not necessarily add up to 100% because the denomintors are not the same.</description>
        <time_frame>Up to 72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oberservation Arm</title>
            <description>To assess safety and device performance for the Hospital Glucose Managment system</description>
          </group>
        </group_list>
        <measure>
          <title>Functionality of HGMS: Alerts and Alarms - % of Hypo False Alert</title>
          <description>Definition of % of hypo false alert: within 30 minutes before or after the sensor alarmed at 70 mg/dL, there is no reference blood glucose value (i-STAT) that goes below 70 mg/dL. The % of hypo false alert was calculated as: total number of false events divided by total number of events from all 19 participants. NOTE: % of Hypo False Alert and % Hypo Event Correctly Detected do not necessarily add up to 100% because the denomintors are not the same.</description>
          <units>percentage of all alerts</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% of false alert</param_type>
            <param_value>85.8</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Functionality of HGMS: Alerts and Alarms - % of Hyper False Alert</title>
        <description>Definition of % of Hyper False Alert: within 30 minutes before or after the sensor alarmed at 250 mg/dL, there is no reference blood glucose value (i-STAT) that goes above 250mg/dL . The % of hyper false alert was calculated as: total number of false events divided by total number of events from all 19 participants. NOTE: % of Hyper False Alert and % Hyper Event Correctly Detected do not necessarily add up to 100% because the denomintors are not the same.</description>
        <time_frame>Up to 72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oberservation Arm</title>
            <description>To assess safety and device performance for the Hospital Glucose Managment system</description>
          </group>
        </group_list>
        <measure>
          <title>Functionality of HGMS: Alerts and Alarms - % of Hyper False Alert</title>
          <description>Definition of % of Hyper False Alert: within 30 minutes before or after the sensor alarmed at 250 mg/dL, there is no reference blood glucose value (i-STAT) that goes above 250mg/dL . The % of hyper false alert was calculated as: total number of false events divided by total number of events from all 19 participants. NOTE: % of Hyper False Alert and % Hyper Event Correctly Detected do not necessarily add up to 100% because the denomintors are not the same.</description>
          <units>percentage of all alerts</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% of false alert</param_type>
            <param_value>56.5</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 days for each subject</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Observation Arm</title>
          <description>To assess safety and device performance for the Hospital Glucose Managment system</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Julie Sekella</name_or_title>
      <organization>Medtronic, Inc.</organization>
      <phone>818-576-5000</phone>
      <email>Julie.Sekella@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

